{"title":"明胶/聚乳酸膜与商用聚乳酸膜引导骨再生的比较分析:一项随机临床试验。","authors":"Jing Wang, Wentian Chen, Min Huang, Zhitong Zhong, Pei Wang, Runfa Wu","doi":"10.12659/MSM.944713","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND This study included 32 patients with single missing teeth and alveolar bone defects and aimed to compare outcomes from guided bone regeneration with a gelatin/polylactic acid (GT/PLA) barrier membrane and a Guidor® bioresorbable matrix barrier dental membrane. MATERIAL AND METHODS A total of 32 participants were recruited in the clinical study, with single missing teeth and alveolar bone defects, requiring guided bone regeneration (32 missing teeth in total). They were randomly divided into the GT/PLA membrane group (experimental) and Guidor® membrane group (control) by the envelope method (n=16). Both membranes were used intraoperatively to cover the bone substitute material. Cone beam computed tomography (CBCT) was performed immediately and at 6 months after surgery to assess the amount of bone resorption. In addition, the osteogenic efficacy was calculated. The soft tissue index (STI), wound healing, membrane exposure, and incidence of infection in the operative area were evaluated. RESULTS The implant survival rate was 100% in both groups. The average bone resorption was 148.54±107.42 mm³ in the experimental group and 185.25±85.31 mm³ in the control group (P=0.163); the osteogenic efficacy was 75% in the experimental group and 56% in the control group (P=0.458). Moreover, the parameters of STI, wound healing, membrane exposure, and incidence of infection in the operative area showed no statistically significant difference between the 2 groups (P>0.05). CONCLUSIONS The GT/PLA barrier membrane yielded non-inferior clinical and imaging results to the GUIDOR® membrane, exhibiting good efficacy and biocompatibility in GBR.</p>","PeriodicalId":48888,"journal":{"name":"Medical Science Monitor","volume":"31 ","pages":"e944713"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715021/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative Analysis of Gelatin/Polylactic Acid and Commercial PLA Membranes for Guided Bone Regeneration: A Randomized Clinical Trial.\",\"authors\":\"Jing Wang, Wentian Chen, Min Huang, Zhitong Zhong, Pei Wang, Runfa Wu\",\"doi\":\"10.12659/MSM.944713\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>BACKGROUND This study included 32 patients with single missing teeth and alveolar bone defects and aimed to compare outcomes from guided bone regeneration with a gelatin/polylactic acid (GT/PLA) barrier membrane and a Guidor® bioresorbable matrix barrier dental membrane. MATERIAL AND METHODS A total of 32 participants were recruited in the clinical study, with single missing teeth and alveolar bone defects, requiring guided bone regeneration (32 missing teeth in total). They were randomly divided into the GT/PLA membrane group (experimental) and Guidor® membrane group (control) by the envelope method (n=16). Both membranes were used intraoperatively to cover the bone substitute material. Cone beam computed tomography (CBCT) was performed immediately and at 6 months after surgery to assess the amount of bone resorption. In addition, the osteogenic efficacy was calculated. The soft tissue index (STI), wound healing, membrane exposure, and incidence of infection in the operative area were evaluated. RESULTS The implant survival rate was 100% in both groups. The average bone resorption was 148.54±107.42 mm³ in the experimental group and 185.25±85.31 mm³ in the control group (P=0.163); the osteogenic efficacy was 75% in the experimental group and 56% in the control group (P=0.458). Moreover, the parameters of STI, wound healing, membrane exposure, and incidence of infection in the operative area showed no statistically significant difference between the 2 groups (P>0.05). CONCLUSIONS The GT/PLA barrier membrane yielded non-inferior clinical and imaging results to the GUIDOR® membrane, exhibiting good efficacy and biocompatibility in GBR.</p>\",\"PeriodicalId\":48888,\"journal\":{\"name\":\"Medical Science Monitor\",\"volume\":\"31 \",\"pages\":\"e944713\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-01-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715021/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Science Monitor\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12659/MSM.944713\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12659/MSM.944713","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
Comparative Analysis of Gelatin/Polylactic Acid and Commercial PLA Membranes for Guided Bone Regeneration: A Randomized Clinical Trial.
BACKGROUND This study included 32 patients with single missing teeth and alveolar bone defects and aimed to compare outcomes from guided bone regeneration with a gelatin/polylactic acid (GT/PLA) barrier membrane and a Guidor® bioresorbable matrix barrier dental membrane. MATERIAL AND METHODS A total of 32 participants were recruited in the clinical study, with single missing teeth and alveolar bone defects, requiring guided bone regeneration (32 missing teeth in total). They were randomly divided into the GT/PLA membrane group (experimental) and Guidor® membrane group (control) by the envelope method (n=16). Both membranes were used intraoperatively to cover the bone substitute material. Cone beam computed tomography (CBCT) was performed immediately and at 6 months after surgery to assess the amount of bone resorption. In addition, the osteogenic efficacy was calculated. The soft tissue index (STI), wound healing, membrane exposure, and incidence of infection in the operative area were evaluated. RESULTS The implant survival rate was 100% in both groups. The average bone resorption was 148.54±107.42 mm³ in the experimental group and 185.25±85.31 mm³ in the control group (P=0.163); the osteogenic efficacy was 75% in the experimental group and 56% in the control group (P=0.458). Moreover, the parameters of STI, wound healing, membrane exposure, and incidence of infection in the operative area showed no statistically significant difference between the 2 groups (P>0.05). CONCLUSIONS The GT/PLA barrier membrane yielded non-inferior clinical and imaging results to the GUIDOR® membrane, exhibiting good efficacy and biocompatibility in GBR.
期刊介绍:
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles in Clinical Medicine and related disciplines such as Epidemiology and Population Studies, Product Investigations, Development of Laboratory Techniques :: Diagnostics and Medical Technology which enable presentation of research or review works in overlapping areas of medicine and technology such us (but not limited to): medical diagnostics, medical imaging systems, computer simulation of health and disease processes, new medical devices, etc. Reviews and Special Reports - papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics. Meta-analyses are considered as reviews. A special attention will be paid to a teaching value of a review paper.
Medical Science Monitor is internationally indexed in Thomson-Reuters Web of Science, Journals Citation Report (JCR), Science Citation Index Expanded (SCI), Index Medicus MEDLINE, PubMed, PMC, EMBASE/Excerpta Medica, Chemical Abstracts CAS and Index Copernicus.